Back to Agenda
Session 1: Biosimilars in the US & Europe
Session Chair(s)
Mark McCamish, MEd, PMP
President and Chief Executive Officer
Forty Seven Inc., United States
Speaker(s)
Keynote: Beyond the Finish Line: Biosimilars in the US
Steven Kozlowski, MD
FDA, United States
Director, Office of Biotechnology Products, OPQ, CDER
Biosimilars 2.0 in the EU: Learnings, Challenges, and External Perceptions
Niklas Ekman
Finnish Medicines Agency, Finland
Senior Researcher
The First Biosimilar in the US – The Company Perspective
Mark McCamish, MEd, PMP
Forty Seven Inc., United States
President and Chief Executive Officer
Have an account?